Article metrics

  • citations in SCindeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[=>]
  • visits in previous 30 days:8
  • full-text downloads in 30 days:2
article: 4 from 4  
Back back to result list
Vojnosanitetski pregled
2015, vol. 72, iss. 4, pp. 379-382
article language: English
document type: Case Report

An experience with colistin applied in treatment of imunocompromised patients with peritonitis on peritoneal dialysis


Introduction. Immunocompromised patients, such as those with multiple myeloma on peritoneal dialysis, are particularly susceptible to the occurrence of peritonitis. Case report. We presented a 56-year-old female patient with a 10-year history of multiple myeloma. The patient was on peritoneal dialysis since 2010. During 2012 the patient had the first episode of peritonitis that was successfully managed, but in 2013 the second episode of peritonitis occured. Analysis of dialysate cul-ture and exit site swab revealed the presence of multiresistant Acinetobacter spp., which was susceptible only to colistin. Prompt colistin therapy was administered at the doses of 100,000 units/day during six days, which resulted in complete recovery of the patient, as well as improvement of local abdominal findings. Gram-negative bacteria (genus Acinetobacter) are common causative agents in hospital-acquired infections. Studies confirmed susceptibility of Acinetobacter to colistin, which was also the case with the presented patient. Intravenous administration of colistin resulted in a complete remission of this severe, life-threatening peritonitis. Conclusion. Patients with multiple myeloma and renal failure are highly prone to severe life-threatening infections.



Álvarez-Lara, M., Martín-Malo, A., Aljama-García, P. (2013) New alternatives in the treatment of myeloma kidney. Nefrología, 33(4): 443-7
Borrego-Hinojosa, J., Pérez-del, B.M.P., Biechy-Baldan, M.M., Merino-García, E., Sánchez-Perales, M.C., García-Cortés, M.J., i dr. (2013) Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience. Nefrología, 33(4); 515-23
Chu, H., Zhao, L., Wang, M., Liu, Y., Gui, T., Zhang, J. (2013) Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis. Brazilian journal of infectious diseases, 17(4): 389-94
Đurđević-Mirković, T. (2010) Peritonealna dijaliza - iskustva # Peritoneal dialysis - experiences. Medicinski pregled, vol. 63, br. 11-12, str. 753-757
França, M.S., Lima, S.S.S., Duclou, C.N., Goulart, E.M.A., Romanelli, C. (2013) Antimicrobials and renal failure in neutropenic patients. Brazilian journal of infectious diseases, 17(4): 487-90
Gvozdenović, L., Knežević, V., Knežević, A., Gvozdenović, N., Gojković, Z. (2013) National estimates of severe sepsis (our experience in Novi Sad, Serbia). Brazilian journal of infectious diseases, 17(3): 381-2
Ha, J.F., Chandraratna, H. (2009) Laparoscopic cholecystectomy in chronic ambulatory peritoneal dialysis. Ochsner journal, 9(1): 17-9
Jain, A.K., Blake, P.G. (2006) Non-Pseudomonas Gram-negative peritonitis. Kidney international, 69(7): 1107-9
Korzets, A., Tam, F., Russell, G., Feehally, J., Walls, J. (1990) The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to multiple myeloma. American journal of kidney diseases, 16(3): 216-23
Li, P.K.-T., Szeto, C.C., Piraino, B., Bernardini, J., Figueiredo, A.E., Gupta, A., Johnson, D.W., Kuijper, E.J., Lye, W.-C., Salzer, W., Schaefer, F., Struijk, D.G. (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Peritoneal Dialysis International, 30(4): 393-423
Medić, D., Mihajlović-Ukropina, M., Gusman, V., Jelesić, Z., Milosavljević, B. (2011) Carbapenems resistance of Acinetobacter spp strains isolated from wound swabs during 2009-2010. Medicinski pregled, vol. 64, br. 11-12, str. 583-587
Netto, B., Vieira, B.J., Hermes, D.M., Ribeiro, V.B., Zavascki, A.P. (2013) In vitro activity of non-bactericidal concentrations of polymyxin B in combination with other antimicrobials against OXA-23-producing carbapenem-resistant Acinetobacter baumannii. Brazilian journal of infectious diseases, 17(4): 502-4
Pérez, F.M., Rodríguez-Carmona, A., García-Naveiro, R., Rosales, M., Villaverde, P., Valdés, F. (2005) Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Peritoneal dialysis international, 25(3): 274-84
Pérez-Fontán, M., Rodríguez-Carmona, A. (2007) Peritoneal catheter removal for severe peritonitis: landscape after a lost battle. Peritoneal dialysis international, 27(2): 155-8
Prata-Rocha, M.L., Gontijo-Filho, P.P., de Melo, G.B. (2012) Factors influencing survival in patients with multidrug-resistant Acinetobacter baumannii infection. Brazilian journal of infectious diseases, 16(3): 237-41
Rabrenović, V., Kovačević, Z., Jovanović, D., Rabrenović, M., Milović, N., Cerović, S. (2006) Extramedular plasmacytoma in the urinary bladder: Unusual localization. Vojnosanitetski pregled, vol. 63, br. 11, str. 975-978
Shetty, A., Oreopoulos, D.G. (1995) Continuous ambulatory peritoneal dialysis in end-stage renal disease due to multiple myeloma. Peritoneal dialysis international, 15(6): 236-40
Szeto, C.C., Chow, K.M. (2007) Gram-negative peritonitis: The Achilles leel of peritoneal dialysis. Perit Dial Int, 27(2): 267-71
Yang, S., Yoon, H.J., Ki, M.R. (2011) Risk factors for mortality in Acinetobacter bacteremia. Brazilian journal of infectious diseases, 15(5): 501-2